KEGG   ORTHOLOGY: K03914
Entry
K03914                      KO                                     

Name
F2R, PAR1
Definition
coagulation factor II (thrombin) receptor
Pathway
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04024  cAMP signaling pathway
ko04072  Phospholipase D signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04151  PI3K-Akt signaling pathway
ko04610  Complement and coagulation cascades
ko04611  Platelet activation
ko04810  Regulation of actin cytoskeleton
ko05130  Pathogenic Escherichia coli infection
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
   04020 Calcium signaling pathway
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
   04072 Phospholipase D signaling pathway
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
   04024 cAMP signaling pathway
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
   04151 PI3K-Akt signaling pathway
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
 09140 Cellular Processes
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
 09150 Organismal Systems
  09151 Immune system
   04610 Complement and coagulation cascades
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
   04611 Platelet activation
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
  09171 Infectious disease: bacterial
   05130 Pathogenic Escherichia coli infection
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Peptide
   Thrombin
    K03914  F2R, PAR1; coagulation factor II (thrombin) receptor
Other DBs
GO: 0015057
Genes
HSA: 2149(F2R)
PTR: 471510(F2R)
PPS: 100986369(F2R)
GGO: 101144448(F2R)
PON: 100447792(F2R)
NLE: 100607663(F2R)
MCC: 707370(F2R)
MCF: 102137130(F2R)
CSAB: 103223358(F2R)
RRO: 104655485(F2R)
RBB: 108513076(F2R)
CJC: 100400356(F2R)
SBQ: 101048036(F2R)
MMU: 14062(F2r)
MCAL: 110308051(F2r)
MPAH: 110328985(F2r)
RNO: 25439(F2r)
MUN: 110551097(F2r)
CGE: 100758351(F2r)
NGI: 103752270(F2r)
HGL: 101708544(F2r)
CCAN: 109701102(F2r)
OCU: 100351711(F2R)
TUP: 102485895(F2R)
CFA: 488942(F2R)
VVP: 112919743(F2R)
AML: 105240499(F2R)
UMR: 103663554(F2R)
UAH: 113255187
ORO: 101364644(F2R)
ELK: 111148319
FCA: 101100861(F2R)
PTG: 102964799(F2R)
PPAD: 109274968(F2R)
BTA: 526585(F2R)
BOM: 102272347(F2R)
BIU: 109564649(F2R)
BBUB: 102407393(F2R)
CHX: 102187491(F2R)
OAS: 101105757(F2R)
SSC: 100521609(F2R)
CFR: 102506154(F2R)
CDK: 105084810(F2R)
BACU: 103006270(F2R)
LVE: 103078013(F2R)
OOR: 101278325(F2R)
DLE: 111185188(F2R)
PCAD: 102983891(F2R)
ECB: 100073278(F2R)
EPZ: 103540011(F2R)
EAI: 106824041(F2R)
MYB: 102249171(F2R)
MYD: 102770826(F2R)
MNA: 107531201(F2R)
HAI: 109381883(F2R)
DRO: 112307510(F2R)
PALE: 102886001(F2R)
RAY: 107501531(F2R)
MJV: 108383641(F2R) 108389995
LAV: 100668995(F2R)
TMU: 101358047
MDO: 100010071(F2R)
SHR: 100934757(F2R)
PCW: 110216589(F2R)
OAA: 114813183(F2R)
GGA: 427212(F2R)
MGP: 100543186(F2R)
CJO: 107306072(F2R)
NMEL: 110390007(F2R)
ACYG: 106042104(F2R)
TGU: 100220661(F2R)
LSR: 110471304(F2R)
SCAN: 103819537(F2R)
GFR: 102045591(F2R)
FAB: 101809495(F2R)
PHI: 102108910(F2R)
PMAJ: 107215843(F2R)
CCAE: 111940635(F2R)
CCW: 104698561(F2R)
ETL: 114057079(F2R)
FPG: 101917626(F2R)
FCH: 102055206(F2R)
CLV: 102096136(F2R)
EGZ: 104124890(F2R)
NNI: 104013343(F2R)
ACUN: 113489757(F2R)
PADL: 103919756(F2R)
AAM: 106489297(F2R) 106496616
ASN: 102371571(F2R)
AMJ: 102559171(F2R)
PSS: 102462418(F2R)
CMY: 102932450(F2R)
CPIC: 101935056(F2R)
ACS: 100566666(f2r) 107982334
PVT: 110084596 110084597(F2R)
PBI: 103063671(F2R) 103064541
XLA: 108707268(f2r.S) 378526(f2r.L)
XTR: 100493325(f2r)
DRE: 100124597(f2r2.1) 100149161 558477(f2r) 794215 794278(si:dkey-163m14.6) 794365(si:dkey-163m14.7) 799082(si:dkey-163m14.2) 799156 799227
IPU: 108255687(f2r)
PHYP: 113537012(f2r)
EEE: 113568043 113580495(f2r)
TRU: 101072420(f2r) 101078307
NCC: 104954982(f2r)
PRET: 103470430(f2r) 103473499
CVG: 107084527(f2r) 107090355
NFU: 107374832 107393891(f2r)
KMR: 108234532(f2r) 108244740
ALIM: 106517457(f2r)
AOCE: 111572634 111576016(f2r)
CSEM: 103389897 103398127(f2r)
POV: 109626040 109638049(f2r)
LCF: 108873765 108878175(f2r)
SDU: 111228371(f2r) 111239586
SLAL: 111660342(f2r) 111666761
HCQ: 109514170(f2r) 109529262
BPEC: 110156751(f2r) 110157418
MALB: 109957034(f2r) 109967793
ELS: 105014292
PKI: 111836076 111849769(f2r)
LCM: 102349897(F2R) 102362466
 » show all
Reference
  Authors
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR
  Title
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
  Journal
J Clin Invest 103:879-87 (1999)
DOI:10.1172/JCI6042
  Sequence
[hsa:2149]
LinkDB

KEGG   ORTHOLOGY: K04236
Entry
K04236                      KO                                     

Name
F2RL3, PAR4
Definition
coagulation factor II (thrombin) receptor-like 3
Pathway
ko04015  Rap1 signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04610  Complement and coagulation cascades
ko04611  Platelet activation
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
 09150 Organismal Systems
  09151 Immune system
   04610 Complement and coagulation cascades
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
   04611 Platelet activation
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Peptide
   Thrombin
    K04236  F2RL3, PAR4; coagulation factor II (thrombin) receptor-like 3
Other DBs
GO: 0015057
Genes
HSA: 9002(F2RL3)
PTR: 455829(F2RL3)
PPS: 100988111(F2RL3)
GGO: 101133994(F2RL3)
PON: 100447897(F2RL3)
NLE: 100597937(F2RL3)
MCC: 718843(F2RL3)
MCF: 102117109(F2RL3)
CSAB: 103234119(F2RL3)
RRO: 104660989(F2RL3)
CJC: 100396997(F2RL3)
SBQ: 101029013(F2RL3)
MMU: 14065(F2rl3)
MCAL: 110300734(F2rl3)
MPAH: 110337063(F2rl3)
RNO: 116498(F2rl3)
MUN: 110563537(F2rl3)
CGE: 100757293(F2rl3)
NGI: 103726912(F2rl3)
HGL: 101697889(F2rl3)
CCAN: 109701150(F2rl3)
TUP: 102490146(F2RL3)
CFA: 484846(F2RL3)
VVP: 112913182(F2RL3)
AML: 100469728(F2RL3)
UAH: 113256662(F2RL3)
ORO: 101369923(F2RL3)
ELK: 111144372
FCA: 101081027(F2RL3)
PPAD: 109247554(F2RL3)
AJU: 113593493(F2RL3)
BTA: 538963(F2RL3)
BOM: 102270079(F2RL3)
BIU: 109561166(F2RL3)
BBUB: 102415129(F2RL3)
CHX: 106502258(F2RL3)
OAS: 101114699(F2RL3)
SSC: 100514949(F2RL3)
CFR: 102508405(F2RL3)
CDK: 105101898(F2RL3)
BACU: 102999153(F2RL3)
LVE: 103071951(F2RL3)
OOR: 101269646(F2RL3)
DLE: 111166636(F2RL3)
PCAD: 102980399(F2RL3)
ECB: 100069950(F2RL3)
EPZ: 103543162(F2RL3)
EAI: 106846903(F2RL3)
MYB: 102262933(F2RL3)
MYD: 102757438(F2RL3)
MNA: 107534297(F2RL3)
HAI: 109382389(F2RL3)
DRO: 112304954(F2RL3)
PALE: 102891888(F2RL3)
RAY: 107517273(F2RL3)
MJV: 108396895(F2RL3)
LAV: 100653569(F2RL3)
TMU: 101354608
SHR: 100915832(F2RL3)
PCW: 110196207(F2RL3)
OAA: 100080814(F2RL3)
GGA: 420139(F2RL3)
MGP: 100539118(F2RL3)
CJO: 107325388(F2RL3)
NMEL: 110389050(F2RL3)
APLA: 101793551(F2RL3)
ACYG: 106044981(F2RL3)
TGU: 100226169(F2RL3)
SCAN: 103821927(F2RL3)
GFR: 102042205(F2RL3)
FAB: 101815172(F2RL3)
PHI: 102105271(F2RL3)
PMAJ: 107215399(F2RL3)
CCAE: 111940359(F2RL3)
CCW: 104697035(F2RL3)
ETL: 114067117(F2RL3)
FPG: 101910838(F2RL3)
FCH: 102050650(F2RL3)
CLV: 102086529(F2RL3)
EGZ: 104124369(F2RL3)
NNI: 104018724(F2RL3)
ACUN: 113489380(F2RL3)
PADL: 103926444(F2RL3)
AAM: 106495602(F2RL3)
ASN: 102367962(F2RL3)
AMJ: 102563566(F2RL3)
PSS: 102449442(F2RL3)
CMY: 102934302(F2RL3)
CPIC: 101950529(F2RL3)
PVT: 110072559(F2RL3)
PBI: 103055738(F2RL3)
PMUR: 107282270(F2RL3)
TSR: 106549823(F2RL3)
PMUA: 114588579(F2RL3)
GJA: 107121680(F2RL3)
XLA: 108713408(f2rl3.L)
XTR: 100491210(f2rl3)
NPR: 108796708(F2RL3)
DRE: 793315(si:ch211-132p1.2)
IPU: 108268927
PHYP: 113524431
AMEX: 103033291
EEE: 113579927
LCO: 104936645(f2rl3)
MZE: 101471997
ONL: 100711248
OLA: 105353609
XMA: 102217467
XCO: 114139462
PRET: 103471788
CVG: 107082692(f2rl3)
NFU: 107381117
KMR: 108228876(f2rl3)
ALIM: 106533300
AOCE: 111586945(f2rl3)
CSEM: 103390787(f2rl3)
LCF: 108891795
SDU: 111233511(f2rl3)
SLAL: 111665590(f2rl3)
HCQ: 109508332(f2rl3)
BPEC: 110160799(f2rl3)
MALB: 109951102
SALP: 111967009(f2rl3)
ELS: 105028435(f2rl3)
SFM: 108925351
CMK: 103182098(f2rl3)
 » show all
Reference
  Authors
Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR
  Title
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
  Journal
J Clin Invest 103:879-87 (1999)
DOI:10.1172/JCI6042
  Sequence
[hsa:9002]
LinkDB

KEGG   ORTHOLOGY: K04270
Entry
K04270                      KO                                     

Name
P2RY1
Definition
P2Y purinoceptor 1
Pathway
ko04015  Rap1 signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04611  Platelet activation
ko04742  Taste transduction
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04270  P2RY1; P2Y purinoceptor 1
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04270  P2RY1; P2Y purinoceptor 1
 09150 Organismal Systems
  09151 Immune system
   04611 Platelet activation
    K04270  P2RY1; P2Y purinoceptor 1
  09157 Sensory system
   04742 Taste transduction
    K04270  P2RY1; P2Y purinoceptor 1
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04270  P2RY1; P2Y purinoceptor 1
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Base and nucleoside
   Purine / pyrimidine
    K04270  P2RY1; P2Y purinoceptor 1
Other DBs
GO: 0045028
TC: 9.A.14.13.22
Genes
HSA: 5028(P2RY1)
PTR: 470970(P2RY1)
PPS: 100976063(P2RY1)
GGO: 101124805(P2RY1)
PON: 100454035(P2RY1)
NLE: 100585436(P2RY1)
MCC: 708507(P2RY1)
MCF: 102138938(P2RY1)
CSAB: 103241450(P2RY1)
RRO: 104669185(P2RY1)
RBB: 108513163(P2RY1)
CJC: 100391898(P2RY1)
SBQ: 101050405(P2RY1)
MMU: 18441(P2ry1)
MCAL: 110291425(P2ry1)
MPAH: 110320415(P2ry1)
RNO: 25265(P2ry1)
MUN: 110566209(P2ry1)
CGE: 100771693(P2ry1)
NGI: 103743373(P2ry1)
HGL: 101710468(P2ry1)
CCAN: 109699012(P2ry1)
OCU: 100353792(P2RY1)
TUP: 102491707(P2RY1)
CFA: 449621(P2RY1)
VVP: 112932768(P2RY1)
AML: 100469491(P2RY1)
UMR: 103681394(P2RY1)
UAH: 113254080(P2RY1)
ORO: 101373272(P2RY1)
ELK: 111150185
FCA: 101090795(P2RY1)
PTG: 102957049(P2RY1)
PPAD: 109261403(P2RY1)
AJU: 106975191(P2RY1)
BTA: 281963(P2RY1)
BOM: 102266465(P2RY1)
BBUB: 102397800(P2RY1)
CHX: 102186247(P2RY1)
OAS: 101114407(P2RY1)
SSC: 503666(P2RY1)
CFR: 102523888(P2RY1)
CDK: 105094987(P2RY1)
LVE: 103075329
OOR: 101284140(P2RY1)
DLE: 111179322(P2RY1)
PCAD: 102992428(P2RY1)
ECB: 100055494(P2RY1)
EPZ: 103551781(P2RY1)
EAI: 106836577(P2RY1)
MYB: 102256919(P2RY1)
MYD: 102759055(P2RY1)
MNA: 107544675(P2RY1)
HAI: 109373708(P2RY1)
DRO: 112304572(P2RY1)
PALE: 102894220(P2RY1)
RAY: 107518093(P2RY1)
MJV: 108396428(P2RY1)
LAV: 100676913(P2RY1)
TMU: 101361782
MDO: 100020509(P2RY1)
SHR: 100918117(P2RY1)
PCW: 110210130(P2RY1)
OAA: 100080337(P2RY1)
GGA: 396275(P2RY1)
MGP: 100303708(P2RY1) 104909759
CJO: 107318429(P2RY1) 107322920
NMEL: 110398787(P2RY1) 110408299
APLA: 101796159 101804394(P2RY1)
ACYG: 106043561(P2RY1) 106047608
LSR: 110469300 110479915(P2RY1)
FAB: 101815217(P2RY1) 101821424
EGZ: 104122312(P2RY1)
NNI: 104011550(P2RY1) 104019994
ASN: 102379884(P2RY1)
AMJ: 102570289 102573260(P2RY1)
PBI: 103059468 103065757(P2RY1)
PMUR: 107284899(P2RY1) 107296324
TSR: 106543814 106550752(P2RY1)
GJA: 107112786 107123690(P2RY1)
DRE: 100003922(p2ry1) 100537284(si:dkey-78k11.9)
NCC: 104948850 104967501(p2ry1)
POV: 109630007(p2ry1) 109643098
HCQ: 109514479 109518514(p2ry1)
BPEC: 110154003 110163623(p2ry1)
MALB: 109968991(p2ry1) 109969101
LCM: 102354696(P2RY1) 106707169
CMK: 103172808 103176593(p2ry1)
 » show all
Reference
PMID:8579591
  Authors
Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP
  Title
Cloning and chromosomal localization of the human P2Y1 purinoceptor.
  Journal
Biochem Biophys Res Commun 218:783-8 (1996)
DOI:10.1006/bbrc.1996.0139
  Sequence
[hsa:5028]
LinkDB

KEGG   ORTHOLOGY: K04172
Entry
K04172                      KO                                     

Name
FPR1
Definition
formyl peptide receptor 1
Pathway
ko04015  Rap1 signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko05150  Staphylococcus aureus infection
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04172  FPR1; formyl peptide receptor 1
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04172  FPR1; formyl peptide receptor 1
 09160 Human Diseases
  09171 Infectious disease: bacterial
   05150 Staphylococcus aureus infection
    K04172  FPR1; formyl peptide receptor 1
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04172  FPR1; formyl peptide receptor 1
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Peptide
   fMet-Leu-Phe
    K04172  FPR1; formyl peptide receptor 1
Other DBs
GO: 0004982
Genes
HSA: 2357(FPR1)
PTR: 456254(FPR1)
PPS: 100975861(FPR1)
GGO: 101133890(FPR1)
PON: 100443662(FPR1)
NLE: 100597664(FPR1)
MCC: 719782(FPR1)
MCF: 102137074(FPR1)
CSAB: 103235144(FPR1)
RRO: 104672700(FPR1)
RBB: 108524153(FPR1)
CJC: 100414855(FPR1)
MMU: 14293(Fpr1)
MCAL: 110284264(Fpr1)
MPAH: 110338420(Fpr1)
RNO: 292409(Fpr1)
CGE: 100758056(Fpr1)
NGI: 103750323(Fpr1)
HGL: 101707455(Fpr1)
CCAN: 109700201(Fpr1)
OCU: 100009153(FPR1)
TUP: 102475967(FPR1)
LAV: 100668044(FPR1)
TMU: 101345132
 » show all
Reference
PMID:2176894
  Authors
Boulay F, Tardif M, Brouchon L, Vignais P
  Title
The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors.
  Journal
Biochemistry 29:11123-33 (1990)
DOI:10.1021/bi00502a016
  Sequence
[hsa:2357]
LinkDB

KEGG   ORTHOLOGY: K04289
Entry
K04289                      KO                                     

Name
LPAR1, EDG2
Definition
lysophosphatidic acid receptor 1
Pathway
ko04015  Rap1 signaling pathway
ko04072  Phospholipase D signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04151  PI3K-Akt signaling pathway
ko04540  Gap junction
ko04810  Regulation of actin cytoskeleton
ko05130  Pathogenic Escherichia coli infection
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
   04072 Phospholipase D signaling pathway
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
   04151 PI3K-Akt signaling pathway
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
 09140 Cellular Processes
  09144 Cellular community - eukaryotes
   04540 Gap junction
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
  09171 Infectious disease: bacterial
   05130 Pathogenic Escherichia coli infection
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Lipid
   Lysophosphatidic acid
    K04289  LPAR1, EDG2; lysophosphatidic acid receptor 1
Other DBs
GO: 0070915
Genes
HSA: 1902(LPAR1)
PTR: 464655(LPAR1)
PPS: 100981266(LPAR1)
GGO: 101144872(LPAR1)
PON: 100458931(LPAR1)
NLE: 100589911(LPAR1)
MCC: 709208(LPAR1)
MCF: 101864894(LPAR1) 102125640
CSAB: 103219021(LPAR1)
RRO: 104664137(LPAR1)
RBB: 108513979
CJC: 100414340(LPAR1)
SBQ: 101035023(LPAR1)
MMU: 14745(Lpar1)
MCAL: 110292580(Lpar1)
MPAH: 110322872(Lpar1)
RNO: 116744(Lpar1)
MUN: 110554214(Lpar1)
CGE: 100757522(Lpar1)
NGI: 103732526(Lpar1)
HGL: 101713333(Lpar1)
CCAN: 109692877(Lpar1)
OCU: 100355169(LPAR1)
TUP: 102503029(LPAR1)
CFA: 474800(LPAR1)
VVP: 112923052(LPAR1)
AML: 100479569(LPAR1)
UMR: 103678568(LPAR1)
UAH: 113260324(LPAR1)
ORO: 101371767(LPAR1)
ELK: 111145805
FCA: 101092556(LPAR1)
PTG: 102968521(LPAR1)
PPAD: 109269980(LPAR1)
AJU: 106971772(LPAR1)
BTA: 281136(LPAR1)
BOM: 102273019(LPAR1)
BIU: 109563336(LPAR1) 109563337
BBUB: 102406108(LPAR1)
CHX: 102189399(LPAR1)
OAS: 443346(LPAR1)
SSC: 100512581(LPAR1)
CFR: 102522277(LPAR1)
CDK: 105096434
BACU: 103015300(LPAR1)
LVE: 103091078(LPAR1)
OOR: 101274338(LPAR1)
DLE: 111177336(LPAR1)
PCAD: 102992144(LPAR1)
ECB: 100053797(LPAR1)
EPZ: 103546686(LPAR1)
EAI: 106826903(LPAR1)
MYB: 102258769(LPAR1)
MYD: 102762844(LPAR1)
MNA: 107537650(LPAR1)
HAI: 109379349(LPAR1)
DRO: 112304468(LPAR1)
PALE: 102891503(LPAR1)
RAY: 107502626(LPAR1)
MJV: 108408598(LPAR1)
LAV: 100668056(LPAR1)
TMU: 101344103
MDO: 100016607(LPAR1) 103103209
SHR: 100928953(LPAR1) 100932534
OAA: 100077696(LPAR1)
GGA: 427339(LPAR1)
MGP: 100541536(LPAR1) 109363681
CJO: 107306591(LPAR1)
NMEL: 110389432(LPAR1) 110407913
APLA: 101796868 101802482(LPAR1)
ACYG: 106043035(LPAR1) 106046837
TGU: 100223722(LPAR1) 115497772
LSR: 110467706 110467746(LPAR1)
SCAN: 103820340 103821825(LPAR1)
GFR: 102032612 102038748(LPAR1)
FAB: 101814928 101819651(LPAR1)
PHI: 102105561 102111782(LPAR1)
PMAJ: 107198333(LPAR1) 107212973
CCAE: 111937972 111941320(LPAR1)
CCW: 104690481(LPAR1) 104690993
ETL: 114069483 114072958(LPAR1)
FPG: 101920309(LPAR1) 106112258
FCH: 102050804 102058846(LPAR1)
CLV: 102084885(LPAR1) 102089623
EGZ: 104121830 104123052(LPAR1)
NNI: 104017012 104019835(LPAR1)
ACUN: 113487191 113490290(LPAR1)
PADL: 103917222 103921055(LPAR1)
AAM: 106494707 106499585(LPAR1)
ASN: 102382491(LPAR1) 112551204
AMJ: 102563758(LPAR1)
PSS: 102445645(LPAR1) 102453320
CMY: 102929826 102935396(LPAR1)
CPIC: 101932155(LPAR1) 101940038
ACS: 100565601(lpar1)
PVT: 110075502 110077739(LPAR1)
PBI: 103053763(LPAR1) 103055321
TSR: 106544059(LPAR1) 106555676
PMUA: 114585716 114587543(LPAR1)
GJA: 107108929 107114523(LPAR1)
XLA: 373591(lpar1.L) 379403(lpar1.S)
XTR: 100124893(lpar1) 116408597
NPR: 108787629(LPAR1)
DRE: 368461(lpar1)
SANH: 107653498(lpar1)
IPU: 108277333(lpar1)
PHYP: 113544013
EEE: 113577615(lpar1)
TRU: 101075588
LCO: 104927704(lpar1)
NCC: 104964645(lpar1)
MZE: 101487294(lpar1)
ONL: 100691976(lpar1)
OLA: 101164735(lpar1)
XMA: 102222146(lpar1)
XCO: 114149710(lpar1)
PRET: 103473989(lpar1)
CVG: 107091062(lpar1)
NFU: 107396668(lpar1)
KMR: 108232758(lpar1)
ALIM: 106513587(lpar1)
AOCE: 111581611(lpar1)
CSEM: 103390307(lpar1) 103399363
POV: 109646242(lpar1)
LCF: 108880309(lpar1)
SDU: 111237500
SLAL: 111655943
HCQ: 109530147(lpar1)
BPEC: 110166379
MALB: 109960839(lpar1)
ELS: 105026669
SFM: 108936306
PKI: 111842175
LCM: 102349282(LPAR1)
CMK: 103187154(lpar1)
RTP: 109929476
CIN: 100182538
ADF: 107357274
 » show all
Reference
PMID:9070858
  Authors
An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ
  Title
Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid.
  Journal
Biochem Biophys Res Commun 231:619-22 (1997)
DOI:10.1006/bbrc.1997.6150
  Sequence
[hsa:1902]
LinkDB

KEGG   ORTHOLOGY: K04291
Entry
K04291                      KO                                     

Name
LPAR2, EDG4
Definition
lysophosphatidic acid receptor 2
Pathway
ko04015  Rap1 signaling pathway
ko04072  Phospholipase D signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04151  PI3K-Akt signaling pathway
ko04810  Regulation of actin cytoskeleton
ko05130  Pathogenic Escherichia coli infection
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
   04072 Phospholipase D signaling pathway
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
   04151 PI3K-Akt signaling pathway
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
 09140 Cellular Processes
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
  09171 Infectious disease: bacterial
   05130 Pathogenic Escherichia coli infection
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Lipid
   Lysophosphatidic acid
    K04291  LPAR2, EDG4; lysophosphatidic acid receptor 2
Other DBs
GO: 0070915
TC: 9.A.14.2.5
Genes
HSA: 9170(LPAR2)
PTR: 455878(LPAR2)
PPS: 100988354(LPAR2)
GGO: 101126528(LPAR2)
PON: 100458628(LPAR2)
NLE: 100587344(LPAR2)
MCC: 719844(LPAR2)
MCF: 102120852(LPAR2)
CSAB: 103234222(LPAR2)
RRO: 104680662(LPAR2)
RBB: 108515641(LPAR2)
CJC: 100391457(LPAR2)
SBQ: 101048307(LPAR2)
MMU: 53978(Lpar2)
MCAL: 110300387(Lpar2)
MPAH: 110336830(Lpar2)
RNO: 498609(Lpar2)
MUN: 110549164(Lpar2)
CGE: 100753903(Lpar2)
NGI: 103726831(Lpar2)
HGL: 101721970(Lpar2)
CCAN: 109687178(Lpar2)
OCU: 100343700(LPAR2)
TUP: 102502351(LPAR2)
CFA: 484802(LPAR2)
VVP: 112912747(LPAR2)
AML: 100483313(LPAR2)
UMR: 103675138(LPAR2)
UAH: 113256760(LPAR2)
ORO: 101363634(LPAR2)
ELK: 111144147
FCA: 101100950(LPAR2)
PTG: 102966758(LPAR2)
PPAD: 109247675(LPAR2)
AJU: 106969061(LPAR2)
BTA: 509748(LPAR2)
BOM: 102268794(LPAR2)
BIU: 109561368(LPAR2)
BBUB: 102411165(LPAR2)
CHX: 102187119(LPAR2)
OAS: 101104572(LPAR2)
SSC: 100038015(LPAR2)
CFR: 102504628(LPAR2)
CDK: 105103737(LPAR2)
BACU: 103016779(LPAR2)
LVE: 103074802(LPAR2)
OOR: 101287741(LPAR2)
DLE: 111166724(LPAR2)
PCAD: 102986483(LPAR2)
ECB: 102147510(LPAR2)
EPZ: 103561322(LPAR2)
EAI: 106825461(LPAR2)
MYB: 102246865(LPAR2)
MYD: 102761006(LPAR2)
MNA: 107535357(LPAR2)
HAI: 109382376(LPAR2)
DRO: 112305257(LPAR2)
PALE: 102891807(LPAR2)
RAY: 107503740(LPAR2)
MJV: 108401369(LPAR2)
LAV: 100674529(LPAR2)
TMU: 101360086
MDO: 100014105(LPAR2)
SHR: 100915220(LPAR2)
PCW: 110214461(LPAR2)
GGA: 426086(LPAR2)
MGP: 100550166(LPAR2)
CJO: 107307021(LPAR2)
NMEL: 110391060(LPAR2)
APLA: 101789658(LPAR2)
ACYG: 106049475(LPAR2)
TGU: 115491626(LPAR2)
LSR: 110479080(LPAR2)
SCAN: 103825056(LPAR2)
GFR: 102032251(LPAR2)
PHI: 102112903(LPAR2)
PMAJ: 107199132(LPAR2)
CCAE: 111945421(LPAR2)
ETL: 114072973(LPAR2)
FPG: 101923045(LPAR2)
FCH: 102058075(LPAR2)
EGZ: 104135290(LPAR2)
NNI: 104013846(LPAR2)
ACUN: 113490929(LPAR2)
PADL: 103920849(LPAR2)
AAM: 106500202(LPAR2)
ASN: 102369379(LPAR2)
AMJ: 102561509(LPAR2)
PSS: 102447107
CMY: 102942984(LPAR2)
CPIC: 101951112(LPAR2)
ACS: 100565184(lpar2)
PVT: 110071644(LPAR2)
PBI: 103067510(LPAR2)
PMUR: 107287233(LPAR2)
TSR: 106539958(LPAR2)
PMUA: 114592871(LPAR2)
GJA: 107124321(LPAR2)
XLA: 108711685(lpar2.L) 447460(lpar2.S)
XTR: 493190(lpar2)
NPR: 108800357(LPAR2)
DRE: 445184(lpar2a) 567956(lpar2b)
IPU: 108257275(lpar2) 108258779(LPAR2)
AMEX: 103027992 103037183(lpar2)
NCC: 104952496(lpar2)
PRET: 103468756(lpar2) 103474898
CVG: 107090067 107093411(lpar2)
NFU: 107378328(lpar2) 107389755
ALIM: 106522697 106529464(lpar2)
HCQ: 109511043(lpar2)
ELS: 105005707 105023381(lpar2)
LCM: 102356779
CMK: 103174454
LAK: 106163074
 » show all
Reference
PMID:9525886
  Authors
An S, Bleu T, Hallmark OG, Goetzl EJ
  Title
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.
  Journal
J Biol Chem 273:7906-10 (1998)
DOI:10.1074/jbc.273.14.7906
  Sequence
[hsa:9170]
LinkDB

KEGG   ORTHOLOGY: K04294
Entry
K04294                      KO                                     

Name
LPAR3, EDG7
Definition
lysophosphatidic acid receptor 3
Pathway
ko04015  Rap1 signaling pathway
ko04072  Phospholipase D signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04151  PI3K-Akt signaling pathway
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
   04072 Phospholipase D signaling pathway
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
   04151 PI3K-Akt signaling pathway
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Lipid
   Lysophosphatidic acid
    K04294  LPAR3, EDG7; lysophosphatidic acid receptor 3
Other DBs
GO: 0070915
Genes
HSA: 23566(LPAR3)
PTR: 736110(LPAR3)
PPS: 100975023(LPAR3)
GGO: 101142058(LPAR3)
PON: 100448001(LPAR3)
NLE: 100590490(LPAR3)
MCC: 710828(LPAR3)
MCF: 102142911(LPAR3)
CSAB: 103224524(LPAR3)
RRO: 104677501(LPAR3)
RBB: 108527700(LPAR3)
CJC: 100392576(LPAR3)
SBQ: 101044775(LPAR3)
MMU: 65086(Lpar3)
MCAL: 110291198(Lpar3)
MPAH: 110320673(Lpar3)
RNO: 66025(Lpar3)
MUN: 110558300(Lpar3)
CGE: 100759265(Lpar3)
NGI: 103728104(Lpar3)
HGL: 101716212(Lpar3)
CCAN: 109699400(Lpar3)
OCU: 100009484(LPAR3)
TUP: 102495978(LPAR3)
CFA: 490187(LPAR3)
VVP: 112924485(LPAR3)
AML: 100474288(LPAR3)
UMR: 103662965(LPAR3)
ORO: 101363176(LPAR3)
ELK: 111143684
FCA: 101097996(LPAR3)
PTG: 102968459(LPAR3)
PPAD: 109246190(LPAR3)
AJU: 106973342(LPAR3)
BTA: 532829(LPAR3)
BOM: 102268179(LPAR3)
BIU: 109556129(LPAR3)
BBUB: 102388933(LPAR3)
CHX: 102186820(LPAR3)
OAS: 101111138(LPAR3)
SSC: 100113360(LPAR3)
CFR: 102508154(LPAR3)
CDK: 105095047(LPAR3)
BACU: 103013128(LPAR3)
LVE: 103073033(LPAR3)
OOR: 101278115(LPAR3)
DLE: 111178371(LPAR3)
PCAD: 102995933(LPAR3)
ECB: 100052775(LPAR3)
EPZ: 103562992(LPAR3)
EAI: 106824051(LPAR3)
MYB: 102242469(LPAR3)
MYD: 102753374(LPAR3)
MNA: 107543205(LPAR3)
HAI: 109372903(LPAR3)
DRO: 112309315(LPAR3)
PALE: 102880785(LPAR3)
RAY: 107511577(LPAR3)
MJV: 108403785(LPAR3)
LAV: 100655832(LPAR3)
TMU: 101346095
MDO: 100012415(LPAR3)
SHR: 100915601(LPAR3)
PCW: 110209937(LPAR3)
OAA: 100079033(LPAR3)
GGA: 771215(LPAR3)
MGP: 100547842(LPAR3)
CJO: 107317576(LPAR3)
NMEL: 110391062(LPAR3)
APLA: 101793595(LPAR3)
ACYG: 106034114(LPAR3)
TGU: 100225154(LPAR3)
LSR: 110470419(LPAR3)
SCAN: 103814917(LPAR3)
GFR: 102041393(LPAR3)
FAB: 101808273(LPAR3)
PHI: 102111144(LPAR3)
PMAJ: 107208287(LPAR3)
CCAE: 111932850(LPAR3)
CCW: 104695306(LPAR3)
ETL: 114057094(LPAR3)
FPG: 101922607(LPAR3)
FCH: 102053547(LPAR3)
CLV: 102095525(LPAR3)
EGZ: 104122897(LPAR3)
NNI: 104015469(LPAR3)
ACUN: 113483118(LPAR3)
PADL: 103925143(LPAR3)
AAM: 106499684(LPAR3)
ASN: 102368731(LPAR3)
AMJ: 102559286(LPAR3)
PSS: 102451255(LPAR3)
CMY: 102944638(LPAR3)
CPIC: 101939177(LPAR3)
ACS: 100554366(lpar3)
PVT: 110079734(LPAR3)
PBI: 103060593(LPAR3)
PMUR: 107285247(LPAR3)
TSR: 106538543(LPAR3)
PMUA: 114598805(LPAR3)
GJA: 107117296(LPAR3)
XLA: 108714179(lpar3.L) 108715493(lpar3.S)
XTR: 100494791(lpar3)
NPR: 108791384(LPAR3)
DRE: 102216338(lpar3)
SRX: 107715712 107741531(lpar3)
IPU: 108271040
PHYP: 113532147(lpar3)
AMEX: 103032282(lpar3)
EEE: 113586108(lpar3)
TRU: 101073172(lpar3)
LCO: 104931932(lpar3)
NCC: 104954258(lpar3)
MZE: 101478332(lpar3)
ONL: 100698163(lpar3)
OLA: 101172645(lpar3)
XMA: 102221110(lpar3)
XCO: 114151282(lpar3)
PRET: 103464145(lpar3)
CVG: 107087234(lpar3)
NFU: 107392693(lpar3)
KMR: 108230661(lpar3)
ALIM: 106511447(lpar3)
AOCE: 111586262(lpar3)
CSEM: 103393145
POV: 109625857(lpar3)
LCF: 108881288(lpar3)
SDU: 111227715(lpar3)
SLAL: 111650243(lpar3)
HCQ: 109522048(lpar3)
BPEC: 110160088(lpar3)
MALB: 109958221(lpar3)
SASA: 106613437(lpar3)
SALP: 111963165(lpar3)
ELS: 114839650(lpar3)
SFM: 108923470(lpar3) 108935081
LCM: 102355524 102362131(LPAR3)
CMK: 103174698(lpar3) 103180702
RTP: 109924871
CIN: 100186784
EPA: 110240338
SPIS: 111329595
 » show all
Reference
  Authors
Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K
  Title
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
  Journal
J Biol Chem 274:27776-85 (1999)
DOI:10.1074/jbc.274.39.27776
  Sequence
[hsa:23566]
LinkDB

KEGG   ORTHOLOGY: K04275
Entry
K04275                      KO                                     

Name
LPAR4, GPR23
Definition
lysophosphatidic acid receptor 4
Pathway
ko04015  Rap1 signaling pathway
ko04072  Phospholipase D signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04151  PI3K-Akt signaling pathway
ko04810  Regulation of actin cytoskeleton
ko05130  Pathogenic Escherichia coli infection
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
   04072 Phospholipase D signaling pathway
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
   04151 PI3K-Akt signaling pathway
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
 09140 Cellular Processes
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
  09171 Infectious disease: bacterial
   05130 Pathogenic Escherichia coli infection
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Lipid
   Lysophosphatidic acid
    K04275  LPAR4, GPR23; lysophosphatidic acid receptor 4
Other DBs
GO: 0070915
TC: 9.A.14.13.9
Genes
HSA: 2846(LPAR4)
PTR: 465729(LPAR4)
PPS: 100989638(LPAR4)
GGO: 101150616(LPAR4)
PON: 100459511(LPAR4)
NLE: 100588179(LPAR4)
MCC: 707170(LPAR4)
MCF: 101864899(LPAR4)
CSAB: 103232244(LPAR4)
RRO: 104654349(LPAR4)
RBB: 108529808(LPAR4)
CJC: 100395819(LPAR4)
SBQ: 101044548(LPAR4)
MMU: 78134(Lpar4)
MCAL: 110287196(Lpar4)
MPAH: 110313491(Lpar4)
RNO: 302378(Lpar4)
MUN: 110541171(Lpar4)
CGE: 100752179(Lpar4)
NGI: 103737817(Lpar4)
OCU: 100344512(LPAR4)
TUP: 102500888(LPAR4)
CFA: 491978(LPAR4)
VVP: 112909196(LPAR4)
AML: 100477865(LPAR4)
UMR: 103675824(LPAR4)
UAH: 113242104(LPAR4)
ORO: 101363180(LPAR4)
ELK: 111160942
FCA: 101087973(LPAR4)
PTG: 102962731(LPAR4)
PPAD: 109260287(LPAR4)
AJU: 106987200(LPAR4)
BTA: 539738(LPAR4)
BOM: 102277938(LPAR4)
BBUB: 102411978(LPAR4)
CHX: 102184511(LPAR4)
OAS: 101118506(LPAR4)
SSC: 100038017(LPAR4)
CFR: 102505523(LPAR4)
CDK: 105090092(LPAR4)
BACU: 103017315
LVE: 103078023(LPAR4)
OOR: 101276625(LPAR4)
DLE: 111178180(LPAR4)
PCAD: 102976773(LPAR4)
ECB: 100071749(LPAR4)
EPZ: 103561874(LPAR4)
EAI: 106827637(LPAR4)
MYB: 102246973(LPAR4)
MYD: 102762209(LPAR4)
MNA: 107537244(LPAR4)
HAI: 109385677(LPAR4)
DRO: 112317954(LPAR4)
PALE: 102881134(LPAR4)
RAY: 107500228(LPAR4)
LAV: 100656506(LPAR4)
TMU: 101346400
MDO: 100020275(LPAR4)
SHR: 100914083(LPAR4)
PCW: 110193052(LPAR4)
OAA: 114812808(LPAR4)
GGA: 422149(LPAR4)
MGP: 100539306(LPAR4)
CJO: 107312621(LPAR4)
NMEL: 110403160(LPAR4)
ACYG: 106042983(LPAR4)
TGU: 100226504(LPAR4)
LSR: 110474370(LPAR4)
SCAN: 103816438(LPAR4)
GFR: 102036590(LPAR4)
FAB: 101818510(LPAR4)
PHI: 102099403(LPAR4)
PMAJ: 107203848(LPAR4)
CCAE: 111928583(LPAR4)
CCW: 104691290(LPAR4)
ETL: 114065169(LPAR4)
FPG: 101916616(LPAR4)
FCH: 102058845(LPAR4)
CLV: 102084800(LPAR4)
EGZ: 104135969(LPAR4)
NNI: 104012845(LPAR4)
ACUN: 113479996(LPAR4)
PADL: 103919177(LPAR4)
AAM: 106482083(LPAR4)
ASN: 102377038(LPAR4)
AMJ: 102566056(LPAR4)
PSS: 102445780(LPAR4)
CMY: 102946452(LPAR4)
CPIC: 101944244(LPAR4)
ACS: 100556160 100562456(lpar4)
PVT: 110086630(LPAR4)
PBI: 103065158(LPAR4) 103067277(HCAR1)
PMUR: 107289964(LPAR4) 107296113
TSR: 106549815(LPAR4) 106553862
PMUA: 114589214(LPAR4) 114599968
GJA: 107121365(LPAR4) 107125005
XLA: 108700165(lpar4.S) 779407(lpar4.L)
XTR: 780308(lpar4)
NPR: 108795346(LPAR4)
DRE: 794698(lpar4)
IPU: 108268431(lpar4)
PHYP: 113542682(lpar4)
AMEX: 103042068
EEE: 113570362 113574177(lpar4)
LCO: 104920594(lpar4)
NCC: 104946178(lpar4)
MZE: 101469114 101482060(lpar4)
XCO: 114139701
NFU: 107375389
KMR: 108237951
ALIM: 106518132(lpar4)
AOCE: 111562742 111569862(lpar4)
CSEM: 103391316(lpar4)
POV: 109630081(lpar4) 109634450
LCF: 108882745(lpar4)
SDU: 111226560(lpar4)
SLAL: 111668872
HCQ: 109524498(lpar4)
BPEC: 110153794(lpar4)
MALB: 109957477(lpar4)
ELS: 105007557(lpar4)
SFM: 108922905 108925231(lpar4)
LCM: 102353655(LPAR4)
CMK: 103176311 103177830(lpar4)
RTP: 109912325(lpar4) 109927492
MYI: 110442869
DGT: 114517624
 » show all
Reference
  Authors
Noguchi K, Ishii S, Shimizu T
  Title
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
  Journal
J Biol Chem 278:25600-6 (2003)
DOI:10.1074/jbc.M302648200
  Sequence
[hsa:2846]
LinkDB

KEGG   ORTHOLOGY: K08390
Entry
K08390                      KO                                     

Name
LPAR5, GPR92
Definition
lysophosphatidic acid receptor 5
Pathway
ko04015  Rap1 signaling pathway
ko04072  Phospholipase D signaling pathway
ko04151  PI3K-Akt signaling pathway
ko04810  Regulation of actin cytoskeleton
ko05130  Pathogenic Escherichia coli infection
ko05200  Pathways in cancer
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
   04072 Phospholipase D signaling pathway
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
   04151 PI3K-Akt signaling pathway
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
 09140 Cellular Processes
  09142 Cell motility
   04810 Regulation of actin cytoskeleton
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
  09171 Infectious disease: bacterial
   05130 Pathogenic Escherichia coli infection
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Lipid
   Lysophosphatidic acid
    K08390  LPAR5, GPR92; lysophosphatidic acid receptor 5
Genes
HSA: 57121(LPAR5)
PTR: 747759(LPAR5)
PPS: 100974345(LPAR5)
GGO: 101126364(LPAR5)
PON: 100444153(LPAR5)
NLE: 100586980(LPAR5)
MCC: 713283(LPAR5)
MCF: 102146767(LPAR5)
CSAB: 103218464(LPAR5)
RRO: 104680109(LPAR5)
RBB: 108542054(LPAR5)
CJC: 100413340(LPAR5)
SBQ: 101037682(LPAR5)
MMU: 381810(Lpar5)
MCAL: 110297038(Lpar5)
MPAH: 110317128(Lpar5)
RNO: 500317(Lpar5)
MUN: 110548577(Lpar5)
CGE: 100765885(Lpar5)
NGI: 103727518(Lpar5)
HGL: 101716148(Lpar5)
CCAN: 109682765(Lpar5)
OCU: 100347657(LPAR5)
TUP: 102491630(LPAR5)
CFA: 486724(LPAR5)
VVP: 112917350(LPAR5)
AML: 100477983(LPAR5)
UAH: 113257973(LPAR5)
ORO: 101377363(LPAR5)
ELK: 111159825
FCA: 102899848(LPAR5)
PPAD: 109276125(LPAR5)
AJU: 106965444(LPAR5)
BTA: 507598(LPAR5)
BOM: 102276877(LPAR5)
BIU: 109558930(LPAR5)
BBUB: 102407059(LPAR5)
CHX: 102189196(LPAR5)
OAS: 101109610(LPAR5)
SSC: 102161415(LPAR5)
CFR: 102524474(LPAR5)
CDK: 105098214(LPAR5)
BACU: 103015627(LPAR5)
LVE: 103071546(LPAR5)
OOR: 101281432(LPAR5)
PCAD: 102981443(LPAR5)
ECB: 100147585(LPAR5)
EPZ: 103547006(LPAR5)
EAI: 106847340(LPAR5)
MYB: 102250139(LPAR5)
MYD: 102756094(LPAR5)
MNA: 107544026(LPAR5)
HAI: 109373640(LPAR5)
DRO: 112321636(LPAR5)
PALE: 102892521(LPAR5)
RAY: 107519844(LPAR5)
MJV: 108387620(LPAR5)
LAV: 100674432(LPAR5)
TMU: 101343136
MDO: 100015472(LPAR5)
SHR: 100922143(LPAR5)
PCW: 110213879(LPAR5)
OAA: 114807801(LPAR5)
GGA: 418279(LPAR5)
MGP: 100547557(LPAR5)
CJO: 107318862(LPAR5)
NMEL: 110398598(LPAR5)
APLA: 101804147(LPAR5)
ACYG: 106047848(LPAR5)
TGU: 100229694(LPAR5)
LSR: 110480807(LPAR5)
SCAN: 103827152(LPAR5)
GFR: 102041046(LPAR5)
FAB: 101812796(LPAR5)
PHI: 102113993(LPAR5)
PMAJ: 107212790(LPAR5)
CCAE: 111938362(LPAR5)
CCW: 104687119(LPAR5)
ETL: 114058191(LPAR5)
FPG: 101917980(LPAR5)
FCH: 102057164(LPAR5)
CLV: 102090478(LPAR5)
EGZ: 104126530(LPAR5)
NNI: 104009404(LPAR5)
ACUN: 113486812(LPAR5)
PADL: 103922014(LPAR5)
AAM: 106497200(LPAR5)
ASN: 102383882(LPAR5)
AMJ: 102573900(LPAR5)
PSS: 102456044(LPAR5)
CMY: 102947899(LPAR5)
CPIC: 101935808(LPAR5)
ACS: 100566703(lpar5)
PVT: 110084627(LPAR5)
PBI: 103048306(LPAR5)
PMUR: 107285764(LPAR5)
TSR: 106548359(LPAR5)
PMUA: 114588139(LPAR5)
GJA: 107118407(LPAR5)
XLA: 108696063(lpar5.L) 108697350(lpar5.S)
XTR: 100216171(lpar5)
NPR: 108784390(LPAR5)
OTW: 112260400
LCM: 102346747(LPAR5)
RTP: 109925950(lpar5)
 » show all
Reference
  Authors
Hu J, Oda SK, Shotts K, Donovan EE, Strauch P, Pujanauski LM, Victorino F, Al-Shami A, Fujiwara Y, Tigyi G, Oravecz T, Pelanda R, Torres RM
  Title
Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response.
  Journal
J Immunol 193:85-95 (2014)
DOI:10.4049/jimmunol.1300429
  Sequence
[mmu:381810]
LinkDB

KEGG   ORTHOLOGY: K04266
Entry
K04266                      KO                                     

Name
ADORA2A, ADOR
Definition
adenosine receptor A2a
Pathway
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04024  cAMP signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04270  Vascular smooth muscle contraction
ko05012  Parkinson disease
ko05034  Alcoholism
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04266  ADORA2A, ADOR; adenosine receptor A2a
   04020 Calcium signaling pathway
    K04266  ADORA2A, ADOR; adenosine receptor A2a
   04024 cAMP signaling pathway
    K04266  ADORA2A, ADOR; adenosine receptor A2a
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04266  ADORA2A, ADOR; adenosine receptor A2a
 09150 Organismal Systems
  09153 Circulatory system
   04270 Vascular smooth muscle contraction
    K04266  ADORA2A, ADOR; adenosine receptor A2a
 09160 Human Diseases
  09164 Neurodegenerative disease
   05012 Parkinson disease
    K04266  ADORA2A, ADOR; adenosine receptor A2a
  09165 Substance dependence
   05034 Alcoholism
    K04266  ADORA2A, ADOR; adenosine receptor A2a
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04266  ADORA2A, ADOR; adenosine receptor A2a
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Base and nucleoside
   Adenosine
    K04266  ADORA2A, ADOR; adenosine receptor A2a
Other DBs
GO: 0001609
TC: 9.A.14.3.8
Genes
HSA: 135(ADORA2A)
PTR: 458714(ADORA2A)
PPS: 100970926(ADORA2A)
GGO: 101153142(ADORA2A)
PON: 100445301(ADORA2A)
NLE: 100596960(ADORA2A)
MCC: 707865(ADORA2A)
MCF: 102132487(ADORA2A)
CSAB: 103223064(ADORA2A)
RRO: 104672500(ADORA2A)
RBB: 108540662(ADORA2A)
CJC: 100395031(ADORA2A)
SBQ: 101042110(ADORA2A)
MMU: 11540(Adora2a)
MCAL: 110303741(Adora2a)
MPAH: 110326786(Adora2a)
RNO: 25369(Adora2a)
MUN: 110553862(Adora2a)
CGE: 100762652(Adora2a)
NGI: 103736274(Adora2a)
HGL: 101718082(Adora2a)
CCAN: 109690509(Adora2a)
OCU: 100339944(ADORA2A)
TUP: 102489555(ADORA2A)
CFA: 403960(ADORA2A)
VVP: 112907458(ADORA2A)
AML: 100478431(ADORA2A)
UMR: 103669201(ADORA2A)
UAH: 113247074(ADORA2A)
ORO: 101380968(ADORA2A)
ELK: 111142559
FCA: 101080742(ADORA2A)
PTG: 102957340(ADORA2A)
PPAD: 109277439(ADORA2A)
AJU: 106979687(ADORA2A)
BTA: 617828(ADORA2A)
BOM: 102275057(ADORA2A)
BIU: 109570969(ADORA2A)
BBUB: 102408025(ADORA2A)
CHX: 102183812(ADORA2A)
OAS: 101112926(ADORA2A)
SSC: 503661(ADORA2A)
CFR: 102520969(ADORA2A)
CDK: 105095191(ADORA2A)
BACU: 103008149(ADORA2A)
LVE: 103076694(ADORA2A)
OOR: 101278735(ADORA2A)
DLE: 111163034(ADORA2A)
PCAD: 102995267(ADORA2A)
ECB: 100034039(ADORA2A)
EPZ: 103561852(ADORA2A)
EAI: 106847130(ADORA2A)
MYB: 102250018(ADORA2A)
MYD: 102759680(ADORA2A)
MNA: 107530474(ADORA2A)
HAI: 109394916(ADORA2A)
DRO: 112310837(ADORA2A)
PALE: 102886314(ADORA2A)
RAY: 107500692(ADORA2A)
MJV: 108398879(ADORA2A)
LAV: 100653783(ADORA2A)
TMU: 101346688
MDO: 100029653(ADORA2A)
SHR: 116420902(ADORA2A)
PCW: 110201764(ADORA2A)
OAA: 103166702(ADORA2A)
GGA: 427705(ADORA2A)
MGP: 100539834(ADORA2A)
CJO: 107321476(ADORA2A)
NMEL: 110406400(ADORA2A)
APLA: 101801586(ADORA2A)
ACYG: 106031315(ADORA2A)
TGU: 100221833(ADORA2A)
LSR: 110481322(ADORA2A)
SCAN: 103818244(ADORA2A)
GFR: 102040402(ADORA2A)
FAB: 101811600(ADORA2A)
PHI: 102111270(ADORA2A)
PMAJ: 107211839(ADORA2A)
CCAE: 111936631(ADORA2A)
CCW: 104688572(ADORA2A)
ETL: 114061523(ADORA2A)
FPG: 101924881(ADORA2A)
FCH: 102052336(ADORA2A)
CLV: 102087090(ADORA2A)
EGZ: 104130134(ADORA2A)
NNI: 104011488(ADORA2A)
ACUN: 113486220(ADORA2A)
PADL: 103922677(ADORA2A)
AAM: 106486321(ADORA2A)
ASN: 102368757 102370706(ADORA2A)
AMJ: 102571514(ADORA2A) 106739353
PSS: 102461606(ADORA2A)
CMY: 102930580(ADORA2A) 102946266
CPIC: 101935989 101941997(ADORA2A) 101950165
ACS: 100554785(adora2a)
PVT: 110081998(ADORA2A)
TSR: 106550153
PMUA: 114586537(ADORA2A)
GJA: 107108096 107115074(ADORA2A)
XLA: 444540(adora2a.S) 495175(adora2a.L)
XTR: 100127551(adora2a) 100489755
NPR: 108787795(ADORA2A) 108804252
DRE: 561701(adora2aa) 566118(adora2ab)
IPU: 108278457(ADORA2A)
PHYP: 113542994(adora2a)
AMEX: 103047110
EEE: 113573461(adora2a)
TRU: 101071006(adora2a) 101073338
LCO: 104926376(adora2a) 104931643
NCC: 104945408
MZE: 101475018(adora2a) 101480031
ONL: 100701288(adora2a) 100704683
OLA: 101169043(adora2a) 101174205
XMA: 102216651 102231510(adora2a)
XCO: 114150174 114154586(adora2a)
PRET: 103457559 103469519(adora2a) 103473602
CVG: 107098774(adora2a) 107099961
NFU: 107393489(adora2a) 107397223
KMR: 108232624 108234918(adora2a)
AOCE: 111567160(adora2a) 111573908
CSEM: 103389390 103397442(adora2a)
SLAL: 111647869(adora2a) 111652981 111670362
BPEC: 110163387(adora2a) 110174158
MALB: 109959608(adora2a) 109965655 109968812
CMK: 103184073(adora2a)
DME: Dmel_CG9753(AdoR)
DER: 6554220
DSE: 6612822
DSI: Dsimw501_GD17311(Dsim_GD17311)
DAN: 6498997
DSR: 110186564
DPE: 6595047
DMN: 108156016
DWI: 6650145
DAZ: 108619450
DNV: 108659061
DHE: 111594513
DVI: 6633177
MDE: 101890696
LCQ: 111678925
AGA: AgaP_AGAP000445(GPRADS)
AAG: 5575639
AME: 411420
BIM: 100744416
BTER: 100650756
CCAL: 108626374
OBB: 114873218
AEC: 105149426
ACEP: 105627102
PBAR: 105427765
VEM: 105561585
HST: 105184423
DQU: 106747078
CFO: 105257858
LHU: 105671009
PGC: 109863534
OBO: 105280973
PCF: 106789484
NVI: 100123175
CSOL: 105359100
TCA: 103314255
DPA: 109539627
NVL: 108560448
BMOR: 101736582
PMAC: 106720317
PRAP: 110999447
HAW: 110372575
TNL: 113491710
PXY: 105386685
API: 100570822
DNX: 107162618
RMD: 113552784
CLEC: 106664388
ZNE: 110839220
FCD: 110856968
PVM: 113800524
TUT: 107368643
DPTE: 113790608
PTEP: 107436314
CBR: CBG21888
PCAN: 112569912
MYI: 110450467
LAK: 106158849
DGT: 114532528
 » show all
Reference
PMID:8670304
  Authors
Le F, Townsend-Nicholson A, Baker E, Sutherland GR, Schofield PR
  Title
Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A.
  Journal
Biochem Biophys Res Commun 223:461-7 (1996)
DOI:10.1006/bbrc.1996.0916
  Sequence
[hsa:135]
LinkDB

KEGG   ORTHOLOGY: K04267
Entry
K04267                      KO                                     

Name
ADORA2B
Definition
adenosine receptor A2b
Pathway
ko04015  Rap1 signaling pathway
ko04020  Calcium signaling pathway
ko04080  Neuroactive ligand-receptor interaction
ko04270  Vascular smooth muscle contraction
ko05034  Alcoholism
Brite
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04015 Rap1 signaling pathway
    K04267  ADORA2B; adenosine receptor A2b
   04020 Calcium signaling pathway
    K04267  ADORA2B; adenosine receptor A2b
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K04267  ADORA2B; adenosine receptor A2b
 09150 Organismal Systems
  09153 Circulatory system
   04270 Vascular smooth muscle contraction
    K04267  ADORA2B; adenosine receptor A2b
 09160 Human Diseases
  09165 Substance dependence
   05034 Alcoholism
    K04267  ADORA2B; adenosine receptor A2b
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04030 G protein-coupled receptors
    K04267  ADORA2B; adenosine receptor A2b
G protein-coupled receptors [BR:ko04030]
 Rhodopsin family
  Base and nucleoside
   Adenosine
    K04267  ADORA2B; adenosine receptor A2b
Other DBs
GO: 0001609
Genes
HSA: 136(ADORA2B)
PTR: 455009(ADORA2B)
PPS: 100994290(ADORA2B)
GGO: 101148779(ADORA2B)
PON: 100448500(ADORA2B)
NLE: 100600364(ADORA2B)
MCC: 696848(ADORA2B)
MCF: 102123462(ADORA2B)
CSAB: 103242456(ADORA2B)
RRO: 104681441(ADORA2B)
RBB: 108522165(ADORA2B)
CJC: 100388327(ADORA2B)
SBQ: 101044944(ADORA2B)
MMU: 11541(Adora2b)
MCAL: 110305306(Adora2b)
MPAH: 110332259(Adora2b)
RNO: 29316(Adora2b)
MUN: 110549785(Adora2b)
CGE: 100759954(Adora2b)
NGI: 103727344(Adora2b)
HGL: 106007570(Adora2b)
CCAN: 109699496(Adora2b)
OCU: 100008951(ADORA2B)
TUP: 102488122(ADORA2B)
CFA: 403410(ADORA2B)
VVP: 112924933(ADORA2B)
AML: 100464166(ADORA2B)
UMR: 103658552(ADORA2B)
UAH: 113271262(ADORA2B)
ORO: 101362544(ADORA2B)
ELK: 111139483
FCA: 109494208(ADORA2B)
PTG: 102961941(ADORA2B)
PPAD: 109245813(ADORA2B)
AJU: 106981421(ADORA2B)
BTA: 529760(ADORA2B)
BIU: 109573399(ADORA2B)
BBUB: 102406905(ADORA2B)
CHX: 102179134(ADORA2B)
OAS: 101107715(ADORA2B)
SSC: 606745(ADORA2B)
CFR: 102517454(ADORA2B)
CDK: 105085087(ADORA2B)
BACU: 102998682(ADORA2B)
LVE: 103078017(ADORA2B)
OOR: 101286598(ADORA2B)
DLE: 111167746(ADORA2B)
PCAD: 102986621(ADORA2B)
ECB: 100063319(ADORA2B)
EPZ: 103560476(ADORA2B)
EAI: 106838859(ADORA2B)
MYB: 102260920(ADORA2B)
MYD: 102773620(ADORA2B)
MNA: 107524507(ADORA2B)
HAI: 109382179(ADORA2B)
DRO: 112308785(ADORA2B)
PALE: 102894821(ADORA2B)
RAY: 107511058(ADORA2B)
MJV: 108403987(ADORA2B)
LAV: 100675139(ADORA2B)
TMU: 101358749
MDO: 100617435(ADORA2B)
SHR: 100913531(ADORA2B)
PCW: 110222171(ADORA2B)
OAA: 100078270(ADORA2B)
GGA: 395971(ADORA2B)
MGP: 100541323(ADORA2B)
CJO: 107322414(ADORA2B)
NMEL: 110407643(ADORA2B)
APLA: 101800579(ADORA2B)
ACYG: 106045790(ADORA2B)
TGU: 100220469(ADORA2B)
LSR: 110467693(ADORA2B)
SCAN: 103820144(ADORA2B)
GFR: 102041688(ADORA2B)
FAB: 101808372(ADORA2B)
PHI: 102107785(ADORA2B)
PMAJ: 107212777(ADORA2B)
CCAE: 111937793(ADORA2B)
CCW: 104691038(ADORA2B)
ETL: 114061259(ADORA2B)
FPG: 101913216(ADORA2B)
FCH: 102048085(ADORA2B)
CLV: 102095318(ADORA2B)
EGZ: 104121911(ADORA2B)
NNI: 104012188(ADORA2B)
ACUN: 113487115(ADORA2B)
PADL: 103920799(ADORA2B)
AAM: 106493737(ADORA2B)
ASN: 102371776(ADORA2B)
AMJ: 102565084(ADORA2B)
PSS: 102460408(ADORA2B)
CMY: 102936804(ADORA2B)
CPIC: 101951801(ADORA2B)
PVT: 110087390(ADORA2B)
PBI: 103050113
PMUR: 107284456
TSR: 106548851
PMUA: 114585197(ADORA2B)
GJA: 107119561(ADORA2B)
XLA: 108707937 108709185(adora2b.S)
XTR: 100496230(adora2b)
NPR: 108790722(ADORA2B)
DRE: 560100(adora2b)
IPU: 108259885(adora2b)
PHYP: 113531619(adora2b)
AMEX: 103021368
EEE: 113573789(adora2b)
TRU: 101063228(adora2b)
LCO: 104923431(adora2b)
NCC: 104942049(adora2b)
MZE: 101468592(adora2b)
ONL: 100703029(adora2b)
OLA: 101172755(adora2b)
XMA: 102218185(adora2b)
XCO: 114153283(adora2b)
PRET: 103476035(adora2b)
CVG: 107091726(adora2b)
NFU: 107386647(adora2b)
KMR: 108233920(adora2b)
ALIM: 106525392(adora2b)
AOCE: 111575188(adora2b)
CSEM: 103394908
POV: 109628454(adora2b)
LCF: 108893222(adora2b)
SDU: 111222270(adora2b)
SLAL: 111663942(adora2b)
HCQ: 109531117(adora2b)
BPEC: 110165141(adora2b)
MALB: 109960460(adora2b)
SASA: 106567979(adora2b) 106603509
OTW: 112228570 112259357(adora2b)
SALP: 111950047 111980343(adora2b)
ELS: 105027548(adora2b)
SFM: 108935999(adora2b)
PKI: 111854790(adora2b)
LCM: 102353646(ADORA2B)
CMK: 103180544(adora2b)
RTP: 109924532
BFO: 118428575
SPU: 582743
PCAN: 112555159
OBI: 106872814
SPIS: 111326811
DGT: 114521989
 » show all
Reference
PMID:1325798
  Authors
Pierce KD, Furlong TJ, Selbie LA, Shine J
  Title
Molecular cloning and expression of an adenosine A2b receptor from human brain.
  Journal
Biochem Biophys Res Commun 187:86-93 (1992)
DOI:10.1016/S0006-291X(05)81462-7
  Sequence
[hsa:136]
LinkDB

DBGET integrated database retrieval system